RNS60 treatment of mice displaying symptoms of Parkinson’s disease showed significant beneficial effects. The study was published in the Journal of Neuroimmune Pharmacology. The study team at Rush University found that RNS60 treatment elicited profound neuroprotection, which translated to improved motor function of the mice compared to control-treated litter mates. On a molecular level, RNS60 treatment affected similar pathways of cellular regulation as those previously shown to react to RNS60 in other models of neurodegenerative diseases including multiple sclerosis and Alzheimer’s disease. This underscores the potential of RNS60 to be developed as treatment for a number of neuronal diseases.
Link to the paper: Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles | SpringerLink